PPD, Inc. (PPD) – FDA
-
AzurRx BioPharma (AZRX) Initiates Phase 2 Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
-
Moderna (MRNA) Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
-
-
-
-
-
Back to PPD Stock Lookup